Neuropsychopharmacology
- A large-scale c-Fos brain mapping study on extinction of cocaine-primed reinstatement2 years ago
- Effects of diazepam on hippocampal blood flow in people at clinical high risk for psychosis2 years ago
- Dopamine D1 receptor in medial prefrontal cortex mediates the effects of TAAR1 activation on chronic stress-induced cognitive and social deficits2 years ago
- Side-effects of mdma-assisted psychotherapy: a systematic review and meta-analysis2 years ago
- Substance P in the medial amygdala regulates aggressive behaviors in male mice2 years ago
- Efficacy and safety of aticaprant, a kappa receptor antagonist, adjunctive to oral SSRI/SNRI antidepressant in major depressive disorder: results of a phase 2 randomized, double-blind, placebo-controlled study2 years ago
- Neural effects of psychedelics: Complexity the key word2 years ago
Journal of Psychopharmacology
- The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation4 years ago
- Impact of drug-induced Parkinsonism and tardive dyskinesia on health-related quality of life in schizophrenia4 years ago
- Activation of the aryl hydrocarbon receptor by clozapine induces preadipocyte differentiation and contributes to endothelial dysfunction4 years ago
- Sex-dependent metabolism of ketamine and (2R,6R)-hydroxynorketamine in mice and humans4 years ago
- Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study4 years ago
- Debunking the myth of ‘Blue Mondays’: No evidence of affect drop after taking clinical MDMA4 years ago
- Prospective memory deficits following acute alcohol consumption5 years ago
European Neuropsychopharmacology
- Invisible wounds: Suturing the gap between the neurobiology, conventional and emerging therapies for posttraumatic stress disorder4 years ago
- Requiem or resurrection: Classic monoamine oxidase inhibitors revisited4 years ago
- A double-blind, randomized, placebo-controlled proof of concept study of the efficacy and safety of Lu AF11167 for persistent negative symptoms in people with schizophrenia4 years ago
- Digital tools for the assessment of pharmacological treatment for depressive disorder: State of the art4 years ago
- A pacemaker for happiness – Transcutaneous vagus nerve stimulation in depression4 years ago
- Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs4 years ago
- Corrigendum to “34th ECNP Congress – Lisbon 2021 Hybrid. [34th ECNP Congress – Lisbon 2021 Hybrid. 53S1. December 2021]” P.0576 Knockdown of 5-HT1A receptor silencer Freud-2 in the frontal cortex affected the behavior and the serotonin system in mice4 years ago